Results
Nectar Lifesciences Q1 Net Loss of ₹13.14 Crore
Nectar Lifesciences reported a standalone net loss of ₹13.14 crore for Q1 FY27, primarily driven by a ₹251.33 crore loss on investments.
The Board appointed Dr. Gunmala Suri as an Additional Director
